54-year-old man with weight gain and muscle weakness

Treatment Orders

A diagnosis of pituitary ACTH-dependent Cushing syndrome is confirmed. At this time, which of the following are appropriate management steps for this patient? (You may select more than one option.)

This is a small dose used in patients with microprolactinomas; if cabergoline is used in CS, it is 4th line treatment or add-on treatment and in much higher dose, eg, 1 mg 3 times a week.





Pegvisomant is 3rd line treatment for acromegaly not CS.